Advertisement
Screener

Sensus Healthcare, Inc. (SRTS) Overview

Sensus Healthcare, Inc. (SRTS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.53; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.06; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.06; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.56$2.99$3.49$4.08$4.76$5.572025-09-292026-09-29$1.78$2.75$4.25$6.57$10.16$15.722021-09-292026-09-29$1.74$2.70$4.19$6.52$10.12$15.722016-09-292026-09-29$1.74$2.70$4.19$6.52$10.12$15.722016-07-262026-09-29$1.74$2.70$4.19$6.52$10.12$15.722016-07-262026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$3.07
Previous close
$3.00
Change
$0.07
Change (%)
2.50%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

SRTS
-22.86%
S&P 500
(m)

1 year

SRTS
-3.15%
S&P 500
(m)

3 years

SRTS
+10.83%
S&P 500
(m)

5 years

SRTS
-12.78%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.53

-0.61-0.43-0.24-0.060.1231 Mar 2025: estimate (m); actual -0.1631 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.0630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0630 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1631 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.5330 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.53(m)(m)
1 Jan 202631 Mar 2026(m)-0.16(m)(m)
1 Jul 202530 Sept 2025(m)-0.06(m)(m)
1 Apr 202530 Jun 2025(m)-0.06(m)(m)
1 Jan 202531 Mar 2025(m)-0.16(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.47

-0.55-0.000.551.091.6431 Dec 2021: estimate (m); actual 0.2531 Dec 2021(m)31 Dec 2022: estimate (m); actual 1.4631 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.0331 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.4131 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.4731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.47(m)(m)
1 Jan 202431 Dec 2024(m)0.41(m)(m)
1 Jan 202331 Dec 2023(m)0.03(m)(m)
1 Jan 202231 Dec 2022(m)1.46(m)(m)
1 Jan 202131 Dec 2021(m)0.25(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 2.29M ■ Earnings -8.75M — Profit margin -382.05%

-10.62M-383.1%-4.16M-259.6%2.30M-136.1%8.76M-12.7%30 Sept 2025: revenue 6.88M; earnings -0.94M; profit margin -13.70%30 Sept 202531 Dec 2025: revenue 4.94M*; earnings -3.17M*; profit margin -64.12%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 3.39M; earnings -2.63M; profit margin -77.37%31 Mar 202630 Jun 2026: revenue 2.29M; earnings -8.75M; profit margin -382.05%30 Jun 2026

31 Dec 2025 ■ Revenue 27.48M ■ Earnings -7.72M — Profit margin -28.09%

-13.99M-29.1%7.61M-0.9%29.21M27.3%50.80M55.4%31 Dec 2022: revenue 44.53M; earnings 24.24M; profit margin 54.44%31 Dec 202231 Dec 2023: revenue 24.41M; earnings 0.48M; profit margin 1.99%31 Dec 202331 Dec 2024: revenue 41.81M; earnings 6.65M; profit margin 15.90%31 Dec 202431 Dec 2025: revenue 27.48M; earnings -7.72M; profit margin -28.09%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$3.07(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$3.07High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning SRTS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-15.48M
Profit margin
-88.45%
Return on assets · 12 month
-30.94%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
28.34K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.97%*
Total return · month
-12.78%*
Total return · quarter
0.33%*
Total return · half year
-21.68%*
Total return · year to date
-22.86%*
Total return · 1 year
-3.15%*
Total return · 3 years
10.83%*
Total return · 5 years
-12.78%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$17.51M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Sensus Healthcare, Inc. Overview

View more →

(m)

(m)

SEC CIK
1494891
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
851 BROKEN SOUND PARKWAY NW, SUITE 215, BOCA RATON, Florida, 33487, United States
Fiscal year end
1231
Phone
561-922-5808

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEPHROS INC (NEPH)United States$0.046B23.02
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
Glucotrack, Inc. (GCTK)United States$0.027B